CoChat

The DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index.

Increased Interleukin-17-Producing γδT Cells in the Brain Exacerbate the Pathogenesis of Sepsis-Associated Encephalopathy and Sepsis-Induced Anxiety in Mice

Open access

Abstract

Overactivated microglia play a key role in sepsis-associated encephalopathy (SAE), although the involvement of T cells is unclear. γδT cells in the brain and meninges regulate normal fear responses via interleukin (IL)-17 in healthy mice. In our sepsis model, the mice showed exacerbated anxious behavior at 10 days post-induction (dpi). At 8 dpi, IL-17 mRNA was significantly upregulated in the brains of septic mice compared with those of control mice. Simultaneously, the number of γδT cells increased in the brains of septic mice in a severity-dependent manner. Additionally, IL-17-producing γδT cells, expressing both the C-X-C motif receptor (CXCR) 6 and the C-C motif receptor (CCR) 6, increased in mice brains, dependent on the severity of sepsis. The frequency of γδT cells in the meninges fluctuated similarly to that in the brain, peaking at 8 dpi of sepsis. Behavioral tests were performed on septic mice after the continuous administration of anti-γδTCR (α-γδTCR) or anti-IL-17A (α-IL-17A) antibodies to deplete the γδT cells and IL-17A, respectively. Compared with IgG-treated septic mice, α-γδTCR- and α-IL-17A-treated septic mice showed suppressed microglial activation and improvements in anxious behavior. These results suggested that CCR6+CXCR6+ IL-17-producing γδT cells in the brain and meninges promote the exacerbation of SAE and sepsis-induced psychological disorders in mice.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jcm12134309

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Monocytes and neutrophils were increased, and the mRNA level of IL−17 was upregulated in the brain on Day 8 after the induction of sepsis. (A–C) Changes in the immune cell populations and mRNA level of IL−17 in the brains of septic mice induced by 0.5 mg/g body weight (BW) of CS injection (n = 3–5 at each time point). (A) Analysis of the microglia by FACS. (B) Analysis of monocytes and neutrophils by FACS. (C) The mRNA level of IL-17 was analyzed by qRT-PCR. (D–I) Relationships among the severity of sepsis, the CS dose, and subsequent changes in immune cell populations and the expression of IL-17. (D) Schematics: 0 (vehicle: 7.5% glycerol-PBS, white), 0.2 mg/g BW intraperitoneally (gray), and 0.5 mg/g BW of CS intraperitoneally (black). (E). Survival study (n = 5, per group). (F) Changes in BW (n = 4–5, per group). (G) Frequency of monocytes and neutrophils. (H) Activated microglia (CD68+ microglia) in the brains of septic mice at 10 dpi. (I) The mRNA level of IL-17 in the brains of septic mice at 10 dpi. Data are expressed as the mean ± SD. Dunnett’s multiple comparison test, * p < 0.05, ** p < 0.01, vs. 0 dpi or the control.
Figure 1 Monocytes and neutrophils were increased, and the mRNA level of IL−17 was upregulated in the brain on Day 8 after the induction of sepsis. (A–C) Changes in the immune cell populations and mRNA level of IL−17 in the brains of septic mice induced by 0.5 mg/g body weight (BW) of CS injection (n = 3–5 at each time point). (A) Analysis of the microglia by FACS. (B) Analysis of monocytes and neutrophils by FACS. (C) The mRNA level of IL-17 was analyzed by qRT-PCR. (D–I) Relationships among the severity of sepsis, the CS dose, and subsequent changes in immune cell populations and the expression of IL-17. (D) Schematics: 0 (vehicle: 7.5% glycerol-PBS, white), 0.2 mg/g BW intraperitoneally (gray), and 0.5 mg/g BW of CS intraperitoneally (black). (E). Survival study (n = 5, per group). (F) Changes in BW (n = 4–5, per group). (G) Frequency of monocytes and neutrophils. (H) Activated microglia (CD68+ microglia) in the brains of septic mice at 10 dpi. (I) The mRNA level of IL-17 in the brains of septic mice at 10 dpi. Data are expressed as the mean ± SD. Dunnett’s multiple comparison test, * p < 0.05, ** p < 0.01, vs. 0 dpi or the control.CC BY · PubMed Central
Figure 2 Severity-dependent increases in IL-17-producing γδT cells in the subacute phase of sepsis. (A) Fold change in the distribution of T cells in the brain after the induction of sepsis at 10 dpi (n = 5). (B) Changes in γδT cells in the brains of septic mice induced by an injection of 0.5 mg/g BW of CS (n = 3–5 at each time point). (C–E) Relationships among the severity of sepsis, the CS dose, and subsequent changes in γδT cells, IL-17+γδT cells, and their maturation. (C) Frequency and number of γδT cells. (D) IL-17+ cells in γδT cells. (E) Expression of CXCR6 and CCR6 in the IL-17+γδT cells in the brain at 10 dpi (n = 5 per group). Data are expressed as the mean ± SD. Dunnett’s multiple comparison test, * p < 0.05, ** p < 0.01, vs. 0 dpi or the control. Tukey–Kramer test, # p < 0.05, ## p < 0.01.
Figure 2 Severity-dependent increases in IL-17-producing γδT cells in the subacute phase of sepsis. (A) Fold change in the distribution of T cells in the brain after the induction of sepsis at 10 dpi (n = 5). (B) Changes in γδT cells in the brains of septic mice induced by an injection of 0.5 mg/g BW of CS (n = 3–5 at each time point). (C–E) Relationships among the severity of sepsis, the CS dose, and subsequent changes in γδT cells, IL-17+γδT cells, and their maturation. (C) Frequency and number of γδT cells. (D) IL-17+ cells in γδT cells. (E) Expression of CXCR6 and CCR6 in the IL-17+γδT cells in the brain at 10 dpi (n = 5 per group). Data are expressed as the mean ± SD. Dunnett’s multiple comparison test, * p < 0.05, ** p < 0.01, vs. 0 dpi or the control. Tukey–Kramer test, # p < 0.05, ## p < 0.01.CC BY · PubMed Central
Figure 3 Meningeal γδT cells also increased in the brain after the induction of sepsis. (A,B) Comparison of the distribution of γδT cells in the meninges and other secondary lymphoid tissues at 8 dpi (n = 5). (A) FACS figures showing γδT cells in the meninges, PBMCs, and spleen; (B) Comparison of the distribution of γδT cells in the meninges and other secondary lymphoid tissues at 8 dpi. (C–E) Relationships among the severity of sepsis, the CS dose, and subsequent changes in γδT cells, IL-17+γδT cells, and their maturation. (C) Frequency and number of γδT cells. (D) IL-17+ cells in γδT cells. (E) Expression of CXCR6 and CCR6 in the IL-17+γδT cells in the meninges at 10 dpi (n = 5 in each group). Abbreviations: PBMC, peripheral blood mononuclear cell; ILN, inguinal lymph node; sCLN, superficial cervical lymph node; dCLN, deep cervical lymph node. Data are expressed as the mean ± SD. Dunnett’s multiple comparison test, ** p < 0.01, vs. 0 dpi or control. Tukey–Kramer test, # p < 0.05, ## p < 0.01.
Figure 3 Meningeal γδT cells also increased in the brain after the induction of sepsis. (A,B) Comparison of the distribution of γδT cells in the meninges and other secondary lymphoid tissues at 8 dpi (n = 5). (A) FACS figures showing γδT cells in the meninges, PBMCs, and spleen; (B) Comparison of the distribution of γδT cells in the meninges and other secondary lymphoid tissues at 8 dpi. (C–E) Relationships among the severity of sepsis, the CS dose, and subsequent changes in γδT cells, IL-17+γδT cells, and their maturation. (C) Frequency and number of γδT cells. (D) IL-17+ cells in γδT cells. (E) Expression of CXCR6 and CCR6 in the IL-17+γδT cells in the meninges at 10 dpi (n = 5 in each group). Abbreviations: PBMC, peripheral blood mononuclear cell; ILN, inguinal lymph node; sCLN, superficial cervical lymph node; dCLN, deep cervical lymph node. Data are expressed as the mean ± SD. Dunnett’s multiple comparison test, ** p < 0.01, vs. 0 dpi or control. Tukey–Kramer test, # p < 0.05, ## p < 0.01.CC BY · PubMed Central
Figure 4 Administration of α-γδTCR to septic mice alleviated anxious behavior. (A–D) Schedule of anti-mouse IgG (black), γδTCR antibody (α-γδTCR; red), or IL-17A antibody (α-IL17A; purple) (n = 5). (A) Schema. (B) Verification of γδT cells in the brain after treatment with each antibody. (C) Changes in BW, anti-mouse IgG (black line), α-γδTCR (red line), and α-IL17 (purple line) (D) Relative brain weight. (E) Immobility time in the FSt at 11 dpi. (F) Latency of the central area (left), locomotive activity (center), and exploration behaviors (right) in the OFt. (G,H) FACS analysis of the immune cells in the brain after treatment with each antibody. (G) Number of microglia. (H) Activated microglia. (I) Number of neutrophils and monocytes. Abbreviations: ND, not detected; NS, no significant difference; MFI, mean fluorescence intensity. Tukey–Kramer test, # p < 0.05, ## p < 0.01.
Figure 4 Administration of α-γδTCR to septic mice alleviated anxious behavior. (A–D) Schedule of anti-mouse IgG (black), γδTCR antibody (α-γδTCR; red), or IL-17A antibody (α-IL17A; purple) (n = 5). (A) Schema. (B) Verification of γδT cells in the brain after treatment with each antibody. (C) Changes in BW, anti-mouse IgG (black line), α-γδTCR (red line), and α-IL17 (purple line) (D) Relative brain weight. (E) Immobility time in the FSt at 11 dpi. (F) Latency of the central area (left), locomotive activity (center), and exploration behaviors (right) in the OFt. (G,H) FACS analysis of the immune cells in the brain after treatment with each antibody. (G) Number of microglia. (H) Activated microglia. (I) Number of neutrophils and monocytes. Abbreviations: ND, not detected; NS, no significant difference; MFI, mean fluorescence intensity. Tukey–Kramer test, # p < 0.05, ## p < 0.01.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 8

Metadata

Authors
Moriyama, N., Saito, M., Ono, Y., Yamashita, K., Aoi, T., & Kotani, J.
Affiliations
  • Kobe University (JP)
  • Kobe University Hospital (JP)
Corresponding author
Saito, Masafumi
Venue
Journal of Clinical Medicine
Publisher
MDPI AG
Published
2023-06-27
Volume
12
Issue
13
Pages
4309
ISSN
2077-0383 (ISSN-L)
OpenAlex
W4382582432
Cited by
7
References
69
Citations by year
2026: 1 · 2025: 3 · 2024: 3
FWCI
0.72
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by)
  • Kobe University Repository Kernel (Kobe University) (submittedVersion, other-oa)
Funders
Japan Society for the Promotion of Science KAKENHI (19K18323, 18K16544, 19K09147, 19K09414)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords
sepsis-associated encephalopathy, γδ T cells, IL-17, microglial activation, meninges, CCR6, CXCR6, T cell depletion, anti-IL-17A antibody, sepsis severity, neuroinflammation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.